freya's glp-1 How my experience is going! @freya.meds link in bio 🤍 Check in! Completed my week

This data allows your provider to determine which medication is driving which symptoms and whether dose adjustments to one or both drugs could improve tolerability without sacrificing efficacy

Hepatic steatosis, evaluated by liver-to-spleen ( L / S ) ratio on CT, was significantly reduced in the luseogliflozin group compared to in the metformin group [48]

Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial

That might mean allowing downregulated receptors to recover their sensitivity

Those differences can impact their effectiveness, tolerability, and suitability for individual patients